Weibo Cai Selected Research

haloalkane dehalogenase (alkylhalidase)

1/2013	HaloTag as a reporter gene: positron emission tomography imaging with (64)Cu-labeled second generation HaloTag ligands.
8/2011	HaloTag: a novel reporter gene for positron emission tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weibo Cai Research Topics

Disease

205	Neoplasms (Cancer) 10/2022 - 12/2005
25	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2005
22	Breast Neoplasms (Breast Cancer) 10/2021 - 07/2006
12	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 12/2006
10	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 03/2006
9	Melanoma (Melanoma, Malignant) 11/2020 - 10/2008
9	Ischemia 01/2018 - 05/2007
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2012
7	Lymphoma (Lymphomas) 01/2022 - 11/2016
6	Lung Neoplasms (Lung Cancer) 01/2019 - 02/2016
5	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 11/2018
5	Myocardial Infarction 04/2021 - 05/2007
5	Reperfusion Injury 04/2021 - 10/2019
5	Glioma (Gliomas) 01/2018 - 07/2006
4	Thyroid Neoplasms (Thyroid Cancer) 07/2021 - 07/2020
4	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 01/2018 - 05/2014
4	Brain Neoplasms (Brain Tumor) 01/2018 - 11/2008
4	Carcinoma (Carcinomatosis) 01/2018 - 11/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017 - 01/2017
4	Carcinogenesis 08/2017 - 01/2008
3	Atherosclerosis 04/2021 - 08/2009
3	Inflammation (Inflammations) 04/2021 - 11/2007
3	Rhabdomyolysis 06/2020 - 01/2016
3	Multiple Myeloma 01/2018 - 01/2016
3	Disease Progression 01/2018 - 06/2014
3	Colorectal Neoplasms (Colorectal Cancer) 11/2008 - 02/2007

Drug/Important Bio-Agent (IBA)

34	Pharmaceutical PreparationsIBA 08/2022 - 12/2005
34	Monoclonal AntibodiesIBA 01/2021 - 09/2006
22	IntegrinsIBA 11/2015 - 12/2005
17	Radioisotopes (Radionuclides)IBA 10/2021 - 01/2008
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 11/2006
17	Integrin alphaVbeta3IBA 11/2008 - 12/2005
16	carotuximabIBA 09/2018 - 03/2012
14	Peptides (Polypeptides)IBA 01/2018 - 12/2005
13	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 10/2013
12	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2008
12	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 11/2006
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
10	EndoglinIBA 04/2021 - 11/2006
10	Chelating AgentsIBA 09/2018 - 06/2007
10	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017 - 12/2006
9	AntibodiesIBA 10/2022 - 12/2005
9	Immunoglobulin G (IgG)IBA 01/2021 - 02/2013
9	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2020 - 01/2016
8	LigandsIBA 01/2018 - 06/2008
7	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022 - 06/2011
7	PorphyrinsIBA 12/2019 - 01/2016
7	arginyl-glycyl-aspartic acidIBA 11/2015 - 01/2006
7	AcidsIBA 01/2012 - 12/2006
6	AntioxidantsIBA 04/2021 - 11/2018
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2021 - 01/2012
6	Thromboplastin (Tissue Factor)IBA 07/2020 - 11/2012
5	daratumumabIBA 01/2022 - 01/2017
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 10/2016
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019 - 12/2007
5	PolymersIBA 09/2018 - 07/2008
5	Cell Adhesion MoleculesIBA 11/2008 - 12/2005
4	Biological ProductsIBA 04/2022 - 02/2008
4	human ERBB2 proteinIBA 10/2021 - 04/2011
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 03/2019 - 07/2008
4	MicellesIBA 01/2019 - 04/2012
4	Liposomes (Liposome)IBA 03/2018 - 05/2016
4	graphene oxideIBA 07/2016 - 04/2013
4	Insulin-Like PeptidesIBA 01/2016 - 04/2011
4	Immunoglobulin Fab FragmentsIBA 07/2015 - 09/2008
3	AntigensIBA 10/2022 - 04/2011
3	Antineoplastic Agents (Antineoplastics)IBA 08/2022 - 07/2020
3	RadiopharmaceuticalsIBA 07/2022 - 12/2006
3	EnzymesIBA 01/2021 - 01/2013
3	Surface-Active Agents (Surfactants)IBA 01/2021 - 03/2017
3	GoldIBA 12/2020 - 09/2008
3	Deferoxamine (Desferal)FDA LinkGeneric 12/2019 - 01/2018
3	Insulin (Novolin)FDA Link 01/2019 - 01/2016
3	Photosensitizing Agents (Photosensitizers)IBA 11/2018 - 01/2016
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2018 - 01/2012
3	Zirconium-89IBA 09/2018 - 01/2016
3	cupric sulfide (CuS)IBA 02/2018 - 02/2014
3	ALT-803IBA 01/2018 - 01/2016
3	IsotopesIBA 01/2018 - 07/2016
3	ALT-836IBA 10/2017 - 11/2012
3	Immunoglobulin FragmentsIBA 01/2017 - 02/2013
3	Carcinoembryonic AntigenIBA 01/2017 - 02/2007
3	NanoconjugatesIBA 07/2016 - 01/2015
3	Firefly LuciferasesIBA 07/2013 - 05/2007
3	ErbB Receptors (EGF Receptor)IBA 04/2011 - 06/2007
3	etaracizumabIBA 11/2008 - 09/2006

Therapy/Procedure

73	Therapeutics 04/2022 - 09/2006
46	Precision Medicine 06/2021 - 01/2008
12	Radiotherapy 01/2022 - 09/2006
10	Photothermal Therapy 06/2021 - 01/2012
10	Intravenous Injections 01/2020 - 11/2011
8	Photochemotherapy (Photodynamic Therapy) 12/2020 - 09/2014
7	Drug Therapy (Chemotherapy) 01/2021 - 09/2006
7	Lasers (Laser) 01/2018 - 02/2008
6	Immunotherapy 01/2020 - 10/2016
5	Radioimmunotherapy 01/2021 - 11/2008
5	Quantum Dots (Quantum Dot) 06/2020 - 04/2006
4	Computer-Assisted Surgery (Image Guided Surgery) 01/2021 - 11/2011
4	Ligation 01/2018 - 02/2008